| Innovative approaches in precision medicine have made their way into clinical trials. This means scientists are accessing the biological resources needed to support discovery and development of new precision medicine therapies. For example, biobanking studies are becoming a routine part of clinical research with vulnerable patient populations. At the same time, the patient related factors and the perceived challenges associated with biobanking, including ethical considerations, often become significant barriers to drug and biomarker development goals.
Want to learn more about how to anticipate considerations associated with precision medicine in clinical trials?
Attend this webinar, and listen to PAREXEL’s team from Early Phase and Genomic Medicine discuss patient centric approaches to study design and execution to overcome these hurdles.
During this webinar you will learn about: The importance of biobanking for disease understanding, biomarker discovery and precision medicine development. Taking a patient centric approach including writing flexible protocols and generating nimble study designs to accommodate hard-to-recruit heterogeneous populations. Ethical challenges and approaches for true informed consent in biobanking research trials. Strategizing recruitment for targeted populations including enrollment rates, forecasting challenges in patient populations and accommodating study partner needs for participation. Educating your participants about complex biobanking information in a conversational way. | 